• 1
    Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 18441850.
  • 2
    Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. HEPATOLOGY 2003; 37: 917923.
  • 3
    Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol 2003; 285: E906E916.
  • 4
    Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity an normal men. J Clin Endocrinol Metab 2002; 87: 30233028.
  • 5
    Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005; 48: 634642.
  • 6
    Pietilainen KH, Rissanen A, Kaprio J, Makimattila S, Hakkinen A-M, Westerbacka J, et al. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. Am J Physiol 2005; 288: E768E774.
  • 7
    Lautamaki R, Borra R, Iozzo P, Komu M, Lehtimaki T, Salmi M, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2006; 291: E282E290.
  • 8
    Perseghin G, Petersen KF, Shulman GI. NMR studies on the mechanism of insulin resistance in man. In: ReavenG, LawsA. Contemporary endocrinology: insulin resistance, chapter 9. Totowa, NJ: Humana Press Inc, 1999: 159177.
  • 9
    Neubauer S. The failing heart: an engine out of fuel. N Engl J Med 2007; 356: 11401151.
  • 10
    Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2004; 288: E462E468.
  • 11
    Perseghin G, Lattuada G, De Cobelli F, Esposito A, Costantino F, Canu T, et al. Reduced intra-hepatic fat content is associated with increased whole body lipid oxidation in patients with type 1 diabetes. Diabetologia 2005; 48: 26152621.
  • 12
    Perseghin G, Fiorina P, De Cobelli F, Scifo P, Esposito A, Danna M, et al. Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a 31P-MRS study. J Am Coll Cardiol 2005; 46: 10851092.
  • 13
    Perseghin G, Lattuada G, De Cobelli F, Ragogna F, Ntali G, Esposito A, et al. Habitual physical activity is associated with the intra-hepatic fat content in humans. Diabetes Care 2007; 30: 683688.
  • 14
    Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936942.
  • 15
    Longo R, Polesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995; 5: 281285.
  • 16
    Hoyumpa AM Jr, Greene HL, Dunn GD, Schenker S. Fatty liver: biochemical and clinical considerations. Am J Dig Dis 1975; 20: 11421170.
  • 17
    Neuschwander BA-T, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. HEPATOLOGY 2003; 37: 12021219.
  • 18
    De Roos A, Doornbos J, Luyten PR, Oosterwaal LJMP, van der Wall EE, den Hollander JA. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy. J Magn Reson Imaging 1992; 2: 711719.
  • 19
    Lamb HJ, Beyerbacht HP, Ouwerkerk R, Doornbos J, Pluim BM, van der Wall EE, et al. Metabolic response of normal human myocardium to high dose atropine-dobutamine stress studied by 31P-MRS. Circulation 1997; 96: 29692977.
  • 20
    Lamb HJ, Doornbos J, den Hollander JA, Luyten PR, Beyerbacht HP, van der Wall EE, et al. Reproducibility of human cardiac 31P-NMR spectroscopy. NMR Biomed 1996; 9: 217227.
  • 21
    Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Postano V, Buzzigoli E, et al. Visceral fat in hypertension influence on insulin resistance and β-cell function. Hypertension 2004; 44: 127133.
  • 22
    Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 14871495.
  • 23
    Perseghin G, Ntali G, De Cobelli F, Lattuada G, Esposito A, Costantino F, et al. Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance. Diabetes Care 2007; 30: 15201527.
  • 24
    Taegtmeyer H, Razeghi P. Heart disease in diabetes: resist the beginnings. J Am Coll Cardiol 2004; 43: 315.
  • 25
    Beyerbacht HP, Vliegen HV, Lamb HJ, Doornbos J, de Roos A, van der Laarse A, et al. Phosphorus magnetic resonance spectroscopy of the human heart: current status and clinical implications. Eur Heart J 1996; 17: 11581166.
  • 26
    Buchthal SD, den Hollander JA, Merz CN, Rogers WJ, Pepine CJ, Reichek N, et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 2000; 342: 829835.
  • 27
    Lamb HJ, Beyerbacht HP, van der Laarse A, Stoel BC, Doornbos J, van der Wall EE, et al. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 1999; 99: 22612267.
  • 28
    Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003; 42: 328335.
  • 29
    Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 2003; 107: 30403046.
  • 30
    Nakae I, Mitsunami K, Omura T, Yabe T, Tsutamoto T, Matsuo S, et al. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol 2003; 42: 15871593.
  • 31
    Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. HEPATOLOGY 2005; 42: 473480.
  • 32
    Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005; 54: 35413546.
  • 33
    Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 13431351.
  • 34
    Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989; 32: 217238.
  • 35
    de las Fuentes L, Herrero P, Peterson LR, Kelly DP, Gropler RJ, Davila-Roman VG. Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease. Hypertension 2003; 41: 8387.
  • 36
    Kankaanpaa M, Lehto H-R, Parkka JP, Komu M, Viljanen A, Ferrannini E, et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006; 91: 46894695.
  • 37
    Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation 2002; 105: 17271733.
  • 38
    Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, et al. Effect of obesity and insulin reistance on myocardial substrate metabolism and efficiency in young women. Circulation 2004; 109: 21912196.
  • 39
    Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Dalla Man C, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Nat Acad Sci U S A 2006; 103: 1827318277.
  • 40
    Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 12211231.
  • 41
    Fairweather D, Rose NR. Inflammatory heart disease: a role for cytokines. Lupus 2005; 14: 646651.